Ignite Creation Date:
2024-10-25 @ 8:06 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06648889
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-15
Brief Title:
Isatuximab in Adult Patients With Cytologic or Molecular RelapsedRefractory CD38 Positive T-cell Acute Lymphoblastic Leukemia
Sponsor:
Organization:
None